Echovirus is a type of virus that resides in the gastrointestinal (GI) tract. These viruses are collectively called Enteroviruses and are second only to rhinoviruses in prevalence. Echovirus derives its name from the ECHO (Enteric Cytopathic Human Orphan) virus. Generally, newborns, children, and young people are vulnerable to echovirus, as adults are more likely to have a developed immunity system; however, they can still become infected. Common symptoms of echovirus infection are cough, sore throat, flu, and rashes. Other symptoms include viral meningitis (that causes intense fever, chills, nausea, vomiting, and headache), myocarditis, encephalitis, and neonatal sepsis. There are no particular control measures or medicines for echovirus since its spread is infectious. However, it can be averted through executing great cleanliness practices and avoidance of shared utensils which may interfere with the transmission of the virus. A quick analysis of such viruses can help the patient from unnecessary treatment and lessen the length of hospitalization, thus reducing the overall expenditure for the treatment.

Major factors driving the global echovirus diagnostics market include rise in prevalence of echovirus infection among all ages of people due to its transmissible nature, technological advancements in molecular diagnostic techniques, and bioterrorism and availability of immunosuppressive drugs in a wide range. According to the CDC (Centers for Disease Control and Prevention), it has been estimated that around 12-14 million cases of symptomatic enterovirus infections are found in the U.S. every year. This means that infections with echovirus and enteroviruses are highly prevalent. In the U.S., the infection is more common during the summer and autumn seasons. Moreover, increase in government health programs, especially in developing nations, is expected to promote the echovirus diagnostics market in these regions.

Usually, echovirus infections are mild in nature and there are no specific treatment available for them. Thus, special tests are not performed for the diagnosis of Echovirus. Echovirus can be confirmed through laboratory tests, such as, rectal culture, stool culture, throat culture, and a spinal fluid culture. Segmentation of the echovirus diagnostics market can be done based on the clinical application, end-user and geography. On the basis of clinical application, the echovirus diagnostics market can be categorized into molecular diagnostics, immunoassays, differential light scattering, information technology, liposomes, flow cytometry, chromatography, gel micro-droplets, diagnostic imaging, monoclonal antibodies, and others. In terms of end-user, the echovirus diagnostics market can be divided into hospitals, commercial/private laboratories, physician offices, and public health labs.

On the basis of geography, the global echovirus diagnostics market can be distributed among five regions, viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the leading share of the echovirus diagnostics market in 2017, followed by Europe. This can be attributed to the presence of a large number of leading echovirus diagnostics market players, technological advancements, and high health care expenditure in North America. In Europe, initiatives taken by the government in research & development are likely to drive the echovirus diagnostics market. Emerging countries of Asia Pacific are expected to witness high growth in the echovirus diagnostics market due to high prevalence of infections, large patient population, and developing health care technology. However, the developing nations of the Middle East and Latin America are expected to witness a sluggish growth due to poor health care facilities and limited investment in research and development.

Key players operating in the global echovirus diagnostics market include Abbott Laboratories, Inc., Gen-Probe, Inc., Danaher Corporation, Becton Dickinson and Company, Novartis Diagnostics, Qiagen, F. Hoffmann-La Roche Ltd., Siemens Ltd., Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Inc., and Wallac OY.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.